catalyst

An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy o — primary completion

as of 2026-07-01
Monitor thisAsk about this
at a glance
2024-05-24 · Actual — This event happened.
Synthesized from structured facts only — each point cited above.

Event

What
An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy o — primary completion
Type
Trial Readout
Date
2024-05-24
Date type
ACTUAL
Phase
Phase 3
This event happened.
relationships
The graph out of here
trial
An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-5)
trial